Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study). - Safe IP; Lacerda MVG; Printes VS; Praia Marins AF; Rebelo Rabelo AL; Costa AA; Tavares MA; Jesus JS; Souza AB; Beraldi-Magalhães F; Neves CP; Monteiro WM; et al. (PloS one, 2020)